Skip to main content
Log in

Clinical studies on bladder tumor-associated antigen in serum of patients with bladder cancer by using monoclonal antibody and sandwich ELISA

  • Published:
Journal of Tongji Medical University Aims and scope Submit manuscript

Summary

Investigations on tumor-associated antigen in the serum of patients with bladder cancer by using monoclonal antibody Hb 7A and sandwich ELISA were carried out on 36 patients with bladder cancer (BCa group), 18 patients with other tissue tumor (OTT group) and 22 normal subjects (control group). The average OD value of Hb 7A antigen of BCa group, OTT group and control group was 0.315±0.033, 0.124±0.026 and 0.12±0.021 respectively. The OD value of Hb 7A antigen in BCa group was significantly higher than that of control group and of OTT group (P< 0.01), but there was no obvious difference between the control group and OTT group (P> 0.05). The positive detection rate in BCa group was 86% (31/36,), while detection in all 22 normal subjects and the 18 patients of OTT group yielded negative results. The results indicated that the method of using McAb Hb 7A and sandwich ELISA, characterized by high specificity and sensitivity, is of value for clinical diagnosis and follow-up of patients with bladder cancer and general survey of persons at high risk of bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lutzeyer W, et al. Prognostic parameters in superficial bladder cancers an analy-sis of 315 cases. J Urol 1982;127:250–2.

    PubMed  CAS  Google Scholar 

  2. Huland H, et al. Long-term mitomycin C instillation after transurethral resec-tion of superficial bladder carcinomas influence on recurrence, progression and survival. J Urol 1984;132:27–9.

    PubMed  CAS  Google Scholar 

  3. Brosman SA. Experience with bacillus Calmette-Guerin in patients with super-ficial bladder cancer. J Urol 1982; 128:27–30.

    PubMed  CAS  Google Scholar 

  4. Lamm DL, et al. Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer. J Urol 1980;124:38–42.

    PubMed  CAS  Google Scholar 

  5. Prout GR, et al. Long-term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not to receive thiotepa. J Urol 1983; 130: 677–80.

    PubMed  Google Scholar 

  6. Umiker W. Accuracy of cytologic diag-nosis of the urinary tract. Acta Cytol 1964;8:186–91.

    Google Scholar 

  7. Chopin DK, et al. Monoclonal antibody against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing. J Urol 1985;134:260–5.

    PubMed  CAS  Google Scholar 

  8. Melamed MR. Flow cytometry of uri-nary bladder. Urol Clin N Am 1984;11: 599–602.

    CAS  Google Scholar 

  9. Liu BC-S, et al. Detection of oncofe-tal bladder antigen of patients with transitional cell carcinoma. J Urol 1987; 137:1258–61.

    PubMed  CAS  Google Scholar 

  10. Bander NH. Monoclonal antibody: slate of the art. J Urol 1987;137:603–12.

    PubMed  CAS  Google Scholar 

  11. 1981:18:29–32.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shun-sheng, Z., Yong-chang, Z., Ren-zhao, H. et al. Clinical studies on bladder tumor-associated antigen in serum of patients with bladder cancer by using monoclonal antibody and sandwich ELISA. Journal of Tongji Medical University 10, 48–51 (1990). https://doi.org/10.1007/BF02909122

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02909122

Key word

Navigation